We are very honoured to count GENFIT among the Sponsors of BioFIT 2021

Home » News » We are very honoured to count GENFIT among the Sponsors of BioFIT 2021

Many thanks to Genfit for joining BioFIT 2021 as a Bronze Sponsor

GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with cholestatic and metabolic chronic liver diseases. GENFIT is a pioneer in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two decades. GENFIT is currently enrolling in ELATIVE™, a Phase 3 clinical trial evaluating elafibranor* in patients with Primary Biliary Cholangitis (PBC). As part of GENFIT’s comprehensive approach to clinical management of patients with liver disease, the Company is also developing NIS4™, a new, non-invasive blood-based diagnostic technology which could enable easier identification of patients with at-risk NASH. NIS4™ technology has been licensed to LabCorp® in the U.S. and Canada for the development and commercialization of a blood-based molecular diagnostic test powered by NIS4™ technology. Nasdaq and Euronext: GNFT.
* Elafibranor is an investigational compound that has not been reviewed and has not received approval by any regulatory authority

Join key BioFIT 2021 sponsors such as Boehringer Ingelheim and Genfit to have the opportunity to:

Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
Highlight your interest in early-stage innovation
Present your ideas and technologies to key innovation players in Life Sciences
Enhance your visibility on an international scale and be recognised as a key innovative actor
Show your expertise thanks to specific communication tools